This study exists to compare options and see whether a digital app or remote support tool offers something meaningfully different. Researchers are trying to understand whether a digital app or remote support tool can give earlier or clearer feedback during care.

In Los Angeles

Schizophrenia, DepressionDrugFrom 18 Years to 45 Years

Countries: United States
Sponsor: University of California, Los Angeles
Condition: Schizophrenia, Depression

View study

CompletedNCT01959035

Aripiprazole Once-monthly in people with Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In San Diego

SchizophreniaDrugFrom 18 Years to 60 Years

Countries: United States
Sponsor: H. Lundbeck A/S
Condition: Schizophrenia

View study

CompletedNCT01795547

Aripiprazole Once-monthly Versus Paliperidone Palmitate in adults with Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Los Angeles

SchizophreniaDrugFrom 18 Years to 60 Years

Countries: United States
Sponsor: H. Lundbeck A/S
Condition: Schizophrenia

View study

CompletedNCT00102518

Aripiprazole Safety and Tolerability Study

This study is completed in the United States. It focuses on Schizophrenia.

Multiple locations, including Birmingham

Schizophrenia, BipolarityDrugFrom 10 Years to 17 Years

Countries: United States
Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition: Schizophrenia, Bipolarity

View study

CompletedNCT00101569

Aripiprazole Oral Acceptability study

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Anaheim

SchizophreniaDrugOver 18 Years

Countries: United States
Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition: Schizophrenia

View study

CompletedNCT00102479

Aripiprazole Pharmacokinetics (PK) and Tolerability Study in Children and Adolescents

This summary needs review. Please check the official study record and contact the research team for details.

Location not clearly listed

Schizophrenia, BipolarityDrugFrom 10 Years to 17 Years

Countries
Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition: Schizophrenia, Bipolarity

View study

CompletedNCT00276874

Aripiprazole to Reduce Cocaine Relapse

This summary needs review. Please check the official study record and contact the research team for details.

In Lexington

AddictionDrugFrom 18 Years to 50 Years

Countries: United States
Sponsor: Craig Rush
Condition: Addiction

View study

CompletedNCT00198198

Aripiprazole Treatment of Depression in bipolarity

This summary needs review. Please check the official study record and contact the research team for details.

In Indianapolis

Bipolarity, DepressionDrugFrom 18 Years to 65 Years

Countries: United States
Sponsor: Indiana University
Condition: Bipolarity, Depression

View study

CompletedNCT00237874

Aripiprazole Treatment of Prodromal Patients

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Hartford

SchizophreniaDrugFrom 13 Years to 40 Years

Countries: United States
Sponsor: Yale University
Condition: Schizophrenia

View study

TerminatedNCT00169949

Aripiprazole Treatment of the Prodrome

This summary needs review. Please check the official study record and contact the research team for details.

In Glen Oaks

SchizophreniaDrugFrom 13 Years to 22 Years

Countries: United States
Sponsor: Northwell Health
Condition: Schizophrenia

View study

Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.